Skip to main navigation

Contact
Info
CRISPR/Cas9
Programs
& Pipeline
Patients
& Families
Healthcare
Professionals
Investors
& Media
Careers

Email Alerts

Investors

Investor Relations

Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Analyst Coverage
Investor FAQs
Information Request
IR & Media Contacts

Shareholder Services

Investor FAQs
Information Request
Email Alerts
IR & Media Contacts

Email Alerts

Required fields denoted by an asterisk ().

Alert type
SEC Alert
Calendar Alert
News Alert

Email

Leave this field blank

Info

Overview
Leadership
Partners

Healthcare Professionals

Overview

CRISPR/Cas9

What’s CRISPR/Cas9?
How CRISPR/Cas9 Works
Types of Edits
Glossary

Investors & Media

Overview
Press Releases
Scientific Publications & Presentations
Corporate Deck
Events & Presentations
Press Kit

Programs & Pipeline

Our Full-Spectrum Approach
Pipeline
In Vivo Therapies
Ex Vivo Therapies

Careers

Overview

Patients & Families

Our Commitment
Clinical Trials
Community Perspective & Resources
Expanded Access Policy

© Intellia Therapeutics 2021

Cookie Policy
Terms of Use
Privacy Policy

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.